Rafael Holdings, Inc. owns commercial real estate assets and interests in clinical and early stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. Read More The Real Estate segment refers to the real estate holdings, including the building at 520 Broad Street in Newark, New Jersey that houses and the company's associated public garage, an office or data center building in Piscataway, New Jersey, and a portion of a building in Israel that hosts offices for IDT and certain affiliates. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals, research and development, and clinical trials. The company is headquartered in Newark, NJ.